1-2 of 2
Runxiang Yang
Close
Sort by
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Yan Gao, MD PhD, Huiqiang Huang, MDPhD, Xiaoxiao Wang, Bing Bai, Yunhong Huang, MD PhD, Haiyan Yang, MD PhD, QingYuan Zhang, MD, Yufu Li, Yan Li, Min Zhou, PhD, Runxiang Yang, Bing Xu, Lihong Liu, MD, Yu Yang, MD PhD, Zhigang Peng, Ding Yu, Hui Zhou, MD PhD, Rong yan Zhang, Huilai Zhang, MD PhD, Junyuan Qi, MD, Yaming Xi, Xiaojing Xing, Zhao Wang, MD, Hongmei Jing, Xiaohong Zhang, Liping Ma, Hongyan Jin, Hongxia Yao, PhD, Yuerong Shuang, Xuefang Xia, Jianfei Xue, Chunlei Li
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-141752
Published: 2020
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
https://doi.org/10.1182/blood-2019-126481
Published: 2019